Lipocalin 2

CRISPR slows the growth of triple-negative breast cancer in mice
Fierce Biotech
Tue, 08/27/19 - 09:56 am
Boston Children's Hospital
CRISPR
gene editing
Lipocalin 2
triple negative breast cancer